Health & Wellness Personalis Inc share price jumps 50% on deals with Merck and Moderna These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space Joseph MortonDecember 19, 2024
Health & Wellness Cross Country Healthcare jumps spike over 60% on merger news The deal represents a 67 per cent premium to Cross Country's closing price on December 3, 2024 Joseph MortonDecember 4, 2024
Medical and Pharmaceutical AI lung cancer screening tech developer, Imidex, seeks buyer at Chicago conference Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform Rowan DunneDecember 2, 2024
Psychedelics U.S. invests millions in psychedelics research to treat chronic pain in older adults The initiative has potential to greatly expand the range of treatment options available Rowan DunneApril 30, 2024
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Investment Ideas The Mugglehead technology roundup: microcap opportunities edition The $1,000 you put into the right micro-cap company could be $2,000, $4,000 or even $10,000 tomorrow, but it could also be zero. Joseph MortonJuly 25, 2022
Cannabis Regular cannabis consumption linked to ‘small’ increase in heart attack risk: study Researchers say their intention isn't to fearmonger, but to educate the public on potential risks Natalia Buendia CalvilloSeptember 9, 2021